Particle.news
Download on the App Store
4 ARTICLES
·
last wk.

Elizabeth Holmes’s Partner Launches Blood-Testing Startup, Haemanthus

Billy Evans’s new venture distances itself from Theranos, focusing on AI-guided diagnostics and veterinary applications.

Theranos founder Elizabeth Holmes, center, and her partner, Billy Evans, right, arrive at the Robert F. Peckham Federal Building and U.S. Courthouse in San Jose, Calif., on Friday, Nov. 18, 2022. (Dai Sugano/Bay Area News Group)
Elizabeth Holmes (C), founder and former CEO of blood testing and life sciences company Theranos, walks with her mother Noel Holmes and partner Billy Evans into the federal courthouse for her sentencing hearing on November 18, 2022 in San Jose, California. – Holmes faces sentencing after being found guilty of defrauding investors and endangering patients in a case that became an indictment of Silicon Valley. US federal prosecutors are seeking a 15-year jail term for Holmes and want her to pay $800 million in restitution to investors. (Photo by Amy Osborne / AFP) (Photo by AMY OSBORNE/AFP via Getty Images)
Image
Image

Overview

  • Haemanthus, founded by Billy Evans, aims to develop diagnostics using Raman spectroscopy and AI-guided light detection.
  • The company has raised $3.5 million from family and friends and is seeking an additional $15 million toward a $50 million goal.
  • Haemanthus plans to validate its technology through veterinary applications before exploring human diagnostics.
  • The startup, which currently has 10–12 employees, has secured a patent for its Raman spectroscopy system.
  • In a public statement, Haemanthus emphasized that Elizabeth Holmes has no involvement, rejecting comparisons to Theranos.